Menarini Group Announces New Data on ELZONRIS (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
Data spans five abstracts including two oral presentations with important findings for…
Alzheimer’s Association Statement on Oral Semaglutide Phase 3 Topline Data Release
- Results Underscore Need for Continued Research and Diverse Treatment PipelineCHICAGO, Nov.…
Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Natures Signal Transduction and Targeted Therapy
Largest prospective clinical trial to-date in a rare subtype of GIST ROCKVILLE,…
National Cancer Institute Broadens Partnership with Medidata to Bring Unmatched Continuity of Medical and Clinical Data for Lead Protocol Organizations
The Medidata Data Experience offering will enable the National Cancer Institute Lead…
Brandwatch Strengthens AI Leadership with Deeper Insights and Expanded Data Coverage
Innovative new capabilities empower marketing teams to turn insight into action —…
6G mobile networks will need up to three times today’s spectrum to meet surging data demands, new GSMA report shows.
Near-term government decisions to avoid future spectrum 'bottlenecks' are needed to benefit…
Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations on Wednesday, November 19, 2025
November 18, 2025 16:30 ET | Source: Protara Therapeutics NEW YORK, Nov.…
Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting
Obagi® saypha® ChIQ™ data selected as a top 10 cosmetic oral abstract…
Jet.AIReports Third Quarter 2025 Financial Results and Shares Progress on the Third Milestone of the Canadian Hyperscale Data Center Project
LAS VEGAS, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Jet.AI. Inc. (“Jet.AI” or…
IBM Study: Chief Data Officers Redefine Strategies as AI Ambitions Outpace Readiness
81% of Chief Data Officers surveyed prioritize investments that accelerate AI capabilities…
